TY - JOUR
T1 - Perspective paper about the joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG-PET/CT external beam radiation treatment planning in lung cancer
AU - Vaz, Sofia C.
AU - Adam, Judit A.
AU - Delgado Bolton, Roberto C.
AU - Vera, Pierre
AU - van Elmpt, Wouter
AU - Herrmann, Ken
AU - Hicks, Rodney J.
AU - Lievens, Yolande
AU - Santos, Andrea
AU - Schöder, Heiko
AU - Dubray, Bernard
AU - Visvikis, Dimitris
AU - Troost, Esther G. C.
AU - de Geus-Oei, Lioe-Fee
N1 - Funding Information: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ken Herrmann reports personal fees from Bayer, personal fees and other from Sofie Biosciences, personal fees from SIRTEX, non-financial support from ABX, personal fees from Adacap, personal fees from Curium, personal fees from Endocyte, grants and personal fees from BTG, personal fees from IPSEN, personal fees from Siemens Healthineers, personal fees from GE Healthcare, personal fees from Amgen, personal fees from Novartis, personal fees from ymabs, personal fees from Aktis Oncology, personal fees from Theragnostics, personal fees from Pharma15, outside the submitted work. - Rodney J. Hicks is on the Scientific Advisory Board of Telix Pharmaceuticals with any honoraria donated to his institution, he is a stock holder in this company, he is also an honorary Trustee of the International Cancer Imaging Society and honorary Board Member of Neuroendocrine Cancer Australia. - All the remaining authors declare no conflict of interest. Publisher Copyright: © 2022
PY - 2022/3/1
Y1 - 2022/3/1
N2 - In “Joint EANM/SNMMI/ESTRO Practice Recommendations for the Use of 2-[18F]FDG-PET/CT External Beam Radiation Treatment Planning in Lung Cancer V1.0” clinical indications for PET-CT in (non-)small cell lung cancer are highlighted and selective nodal irradiation is discussed. Additionally, concepts about target definition, target delineation and treatment evaluation are reviewed.
AB - In “Joint EANM/SNMMI/ESTRO Practice Recommendations for the Use of 2-[18F]FDG-PET/CT External Beam Radiation Treatment Planning in Lung Cancer V1.0” clinical indications for PET-CT in (non-)small cell lung cancer are highlighted and selective nodal irradiation is discussed. Additionally, concepts about target definition, target delineation and treatment evaluation are reviewed.
KW - FDG-PET/CT
KW - Non-small cell lung cancer
KW - Radiation treatment planning
KW - Small cell lung cancer
KW - Treatment response assessment
UR - http://www.scopus.com/inward/record.url?scp=85123756435&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.radonc.2021.12.048
DO - https://doi.org/10.1016/j.radonc.2021.12.048
M3 - Review article
C2 - 35066001
SN - 0167-8140
VL - 168
SP - 37
EP - 39
JO - Radiotherapy and oncology
JF - Radiotherapy and oncology
ER -